GlassScriptPhysician profile
Nitasha Gupta
NPI 1972941748
$43,203.59
in general payments reported to CMS, 2019-2025
30 companies · $26K in 2025
The $26K reported for 2025 was more than what 97% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,742 · 2020: $389 · 2021: $1,025 · 2022: $2,491 · 2023: $1,981 · 2024: $9,951 · 2025: $26K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $29K · Food and Beverage: $7,857 · Travel and Lodging: $554 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $307.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $28,838.38 |
| Food and Beverage | $7,857.43 |
| Travel and Lodging | $553.99 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $307.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $30,936.52 | 2022-2025 | Travoprost Intraocular Implant - Idose, Istent Trabecular Micro-Bypass System Model Is3, Idosetr |
| Abbvie INC. | $1,717.36 | 2022-2025 | |
| Johnson & Johnson Surgical Vision, INC. | $1,609.02 | 2019-2024 | Tecnis Iol, Tecnis Iol, Tecnis Simplicity |
| Sight Sciences, INC. | $1,073.28 | 2020-2024 | Omni Surgical System |
| Alcon Vision LLC | $1,054.75 | 2020-2025 | Rocklatan, Eysuvis, Argos |
| Carl Zeiss Meditec, INC. | $1,050.00 | 2025 | Cirrus Hd-Oct, Quatera 700, Visumax |
| Bausch & Lomb Americas INC. | $957.10 | 2022-2025 | Envista Mx60 Iol, Toric, Miebo |
| Aerie Pharmaceuticals, INC. | $748.49 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $490.23 | 2019-2023 | |
| Allergan, INC. | $484.70 | 2019-2022 | |
| Astellas Pharma US INC | $361.84 | 2024 | Izervay |
| Nova Eye, INC. | $355.96 | 2023-2025 | |
| Heidelberg Engineering, INC. | $307.00 | 2025 | Spectralis |
| Horizon Therapeutics Plc | $273.86 | 2022-2023 | Tepezza |
| Dompe US, INC. | $238.96 | 2021-2025 | Oxervate |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $218.09 | 2022-2023 | Rxsight Injector Cartridge, Rxsight Light Adjustable Lens (Rxlal), Rxsight Contact Lens |
| Sun Pharmaceutical Industries INC. | $201.92 | 2020-2025 | Cequa |
| New World Medical,INC. | $197.76 | 2020-2022 | |
| Tarsus Pharmaceuticals, INC. | $139.78 | 2024-2025 | Xdemvy |
| Amgen INC. | $137.61 | 2024 | Tepezza |
| Biotissue Holdings INC. | $127.15 | 2022 | |
| Oyster Point Pharma, INC. | $110.76 | 2022-2025 | Tyrvaya, Ryzumvi |
| Harrow Eye, LLC | $96.04 | 2024-2025 | Vevye |
| Mallinckrodt Hospital Products INC. | $71.75 | 2024 | Acthar |
| Kala Pharmaceuticals, INC. | $70.41 | 2019-2022 | |
| Oculus Surgical INC. | $59.62 | 2024 | |
| Ocular Therapeutix, INC. | $37.76 | 2023-2025 | Dextenza |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $36.27 | 2019-2020 | |
| Rayner Intraocular Lenses Limited | $27.10 | 2024 | Rayone Aspheric, Rayner Cataract Set 1, Rayone Emv |
| Omeros Corporation | $12.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nitasha Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.